Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body

UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body

University of Alabama at Birmingham researchers will receive $17.8 million in federal funding to attack a key “knowledge gap” in human immunology — how the B cells and antibody-secreting cells that reside in tissues and organs differ from those found in blood. It is an exploration never undertaken in a systematic way, studying many individual people.

These unknown differences among the immune cells may alter resistance to infections, and they may contribute to autoimmune disease and the inflammation that worsens heart failure. They also may play a role in the rejection of transplanted organs, especially the xenotransplantation of organs from pigs to humans, an important advance that is growing closer to clinical testing at UAB.

“Despite the critical role that cells in the immune system play in these disease processes,” said Frances Lund, Ph.D., “we know remarkably little about human immune cells that reside in tissues.”

“At least six of the top 10 causes of death in the United States can be attributed — at least in part — to dysregulated or impaired immunity,” said Lund, the chair of Microbiology at UAB and principal investigator of the National Institutes of Health grant. “These top 10 killers include diseases that are exacerbated or caused by inflammation in tissues like the heart for cardiovascular disease, the brain for Alzheimer’s disease, and the lung for COPD and asthma. They also include diseases exacerbated or caused by failure of immune surveillance or immune protection in tissues that are either infected or contain malignant cells.”

From mouse experiments and human experiments with easily reached tonsils, researchers know that immune cells that are permanent residents in tissues or spend most of their time in organs are very different from immune cells that travel through the blood or lymphoid tissues. They differ in their lifespans, functions, abilities to proliferate and roles in effecting an immune response. However, most human tissues that harbor permanent resident-immune cells are inaccessible.

Gifts of hope

So, the challenge for study of human tissue-resident B cells is how to reach tissues that include bone marrow, the spleen, lymph nodes, the lungs, the small intestine and the omentum, a fatty curtain of tissue that drapes across the abdomen.

The solution involves gifts of life, as families donate organs from brain-dead loved ones for transplantation and donate other vital tissues for research that improves medical care and cures.

UAB works closely with the Birmingham-based Legacy of Hope, Alabama’s organ and tissue donation alliance, formerly known as the Alabama Organ Center. Legacy of Hope evaluates and recovers deceased donor organs for transplant. As part of donors’ research consent, it will recover tissue for the fundamental study of human immunology by Lund and a highly accomplished interdisciplinary group of UAB colleagues.

Legacy of Hope is one of only nine stand-alone centralized organ donation centers in the United States, and it is the only one associated with a research-intensive academic medical center with a strong immunology research community.

Legacy of Hope’s primary mission is to provide organs and tissues for transplant. Legacy of Hope also recognizes the importance of research and the impact it can make on society. “We are pleased we can support a project of this nature due to the generosity of our donors and their families,” said Chris Meeks, executive director Legacy of Hope.

“Through our partnership with the center,” Lund said, “the program will receive primary matched human tissue samples with minimal ischemic damage that cannot be obtained in the same volume or with the same precision in any other institution.”

Three projects

Lund expects to study tissue from 90 to 100 donors over the five-year grant from the National Institute for Allergy and Infectious Diseases. B cells and antibody-secreting cells isolated from the tissues will be carefully cataloged and frozen for further study in three projects.

The first project will study the poorly understood mechanisms that drive development of innate-like B cells, including where are they are located, the traits they exhibit and the antigens they react against. Understanding these mechanisms will help predict susceptibility to serious infections by bacteria like streptococci and pathogenic E. coli. It also will allow development of ways to prevent chronic allergy and autoimmune disease.

The second project will look at human flu-specific B cells and antibody-secreting cells that reside in tissues. Understanding how they contribute to anti-viral immunity will allow rational design of vaccines to elicit the most protective types of memory B cells in appropriate tissues and organs. In recent winters, between 12,000 and 80,000 Americans have died from influenza and its complications, and the effectiveness of vaccination decreases as people age.

The third project will identify B cell populations that contribute to xenograft rejection, particularly B cells specific for swine leukocyte antigens. Xenografts of pig organs into humans would help the more than 1,800 people awaiting lifesaving transplants through Legacy of Hope. Nationwide, the number awaiting transplants is more than 113,000.

The third project will also develop tools to rapidly screen blood of people on the transplant list to identify swine leukocyte antigen reactivity. Although three well-defined carbohydrates that cause xenograft rejection have been removed from genetically engineered pigs, half of humans still have antibodies to lesser-defined antigens that could lead to transplant rejection.

Co-leaders of the first project are John Kearney, Ph.D., distinguished professor of microbiology at UAB, who holds the Endowed Professorship in Immunology, and Rodney King, UAB assistant professor in microbiology. Second project co-leaders are Lund and Troy Randall, Ph.D. At UAB, Lund holds the Charles H. McCauley Chair of Microbiology, and Randall holds The Meyer Foundation William J. Koopman, M.D., Endowed Professorship in Immunology and Rheumatology in the UAB Department of Medicine. The third project leader is Joseph Tector, M.D., Ph.D., a transplant surgeon who is professor of surgery at UAB and founding director of the UAB Xenotransplantation Program.

More than 600-page application

Lund and colleagues first saw the NIH request for applications on Dec. 17, 2017. The due date was the end of March 2018.

Randall, Lund, Tector and Kearney immediately called all hands on deck in their four labs, putting 20 researchers to work full time on preliminary experiments for the U19 grant application. In three and a half months, they demonstrated their ability to collect donor tissues, isolate good numbers of B cells and antibody-secreting cells from the tissues, and analyze the genetic and molecular details of those cells.

Lund calls it a bucketload of work.

The grant application — totaling more than 600 pages — was written in three weeks. Lund and other leaders cited invaluable help from UAB administrative staff, especially the leadership of Carol Ballinger, Ph.D., administrative director of the Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center, and UAB microbiology administrative team members Kristina Sinclair, Huantao “Megan” Lu and Jonathan Averett. Also, Cathy Tarver, MBA, the grants and contracts senior officer for federal submissions in the UAB Office of Sponsored Programs, was invaluable in helping submit the grant application to NIH.

The grant was awarded late last year, and it began this month.

“We are in a lot of meetings right now to get queued up to actually start doing experiments,” Lund said. Besides the project leaders, partners in the tissue collection will be Jayme Locke, M.D., the UAB transplant surgeon who directs the UAB Comprehensive Transplant Institute, and Sam Windham, M.D., the UAB surgeon who is critical care specialist for the Legacy of Hope.

Two key cores for the research will be the tissue collection and repository core and the data analytics and bioinformatics core. The repository core will be led by Matt Tector, Ph.D., assistant professor in the Division of Transplantation in the UAB Department of Surgery; Louis Bridges, M.D., Ph.D., the Anna Lois Waters Professor and director of the Division of Clinical Immunology and Rheumatology in the UAB Department of Medicine; and Anoma Nellore, M.D., assistant professor in the UAB Division of Infectious Diseases and associate medical director, UAB Transplant Infectious Diseases. The bioinformatics core will be led by Alex Rosenberg, Ph.D., associate professor in the UAB Department of Microbiology and member of the UAB Informatics Institute.

A third key core is the B-cell-receptor repertoire, cloning and expression core. Co-leader Randall has developed tools to identify, track and characterize antigen-specific B cells, and co-leader King has developed a high-throughput platform to accelerate analysis of B-cell receptors expressed by specific subsets of antigen-specific B cells. This core will identify clones of B cells in various tissues, determine their relatedness to one another, and define their antigen-binding properties and effector functions.

This new interdisciplinary grant fits goals of UAB’s strategic plan, Forging the Future. These include the culture of collaboration and innovation at UAB. They also include efforts to meet grand challenges, such as the School of Medicine’s research focus on inflammation, infection and immunity, or I3. I3 impacts almost all the diseases studied and treated at UAB, and UAB has responded with unified, interdisciplinary programs in fundamental and clinical inflammation-based research.

Source:

https://www.uab.edu/news/research/item/10410-17-million-grant-will-explore-immune-cells-in-inaccessible-tissues-of-the-human-body

Tagged with:

About author

Related Articles